Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
Altimmune, Inc. (ALT)
Sector: Healthcare; Industry: Biotechnology

Altimmune, Inc., a clinical stage biopharmaceutical company, focused developing treatments for liver disease, immune modulating therapies, and vaccines. The company also develops veterinary product candidates.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-03-01 Hodges Philip Director Sell 6,000 $16.08 $96,480 No
2020-12-10 Schafer Klaus Director Buy 2,000 $11.99 $23,980 No
2020-12-01 Hodges Philip Director Sell 3,727 $12.51 $46,614 No
2020-11-12 Schafer Klaus Director Sell 10,150 $9.91 $100,586 No
2020-11-12 Pisano Wayne Director Sell 10,352 $9.90 $102,485 No
2020-11-12 Harris Matthew Scott Director Sell 4,015 $10.02 $40,230 No
2020-06-15 Venrock Healthcare Capital Partners III, L.P. 10%-Owner Buy 1,500,000 $7.54 $11,310,000 No
2020-05-28 Venrock Healthcare Capital Partners III, L.P. 10%-Owner Buy 1,303,636 $8.74 $11,395,493 No
2020-05-15 VELOCITY PHARMACEUTICAL HOLDINGS LLC 10%-Owner Sell 200,000 $4.79 $957,100 No
2019-09-05 Garg Vipin K President and CEO Buy 20,000 $2.10 $42,000 No
2018-10-09 Pisano Wayne Director Buy 2,000 $4.59 $9,180 No
2018-05-25 Enright William President and CEO Buy 1,300 $0.51 $660 No
2017-06-06 Roberts M Scot Chief Scientific Officer Buy 449 $4.42 $1,985 No
2017-12-29 SAYARE MITCHEL Director Buy 5,100 $1.95 $9,963 No
2017-12-29 SCHAFFER DERACE L Director Buy 97,410 $1.92 $187,450 No
2017-12-27 SCHAFFER DERACE L Director Buy 147,130 $1.76 $259,356 No
2017-12-07 SCHAFFER DERACE L Director Buy 23,745 $1.78 $42,304 No
2017-12-05 SCHAFFER DERACE L Director Buy 26,010 $1.79 $46,588 No
2017-11-30 SCHAFFER DERACE L Director Buy 33,315 $1.91 $63,639 No
2017-11-27 SCHAFFER DERACE L Director Buy 21,808 $2.03 $44,282 No
2017-11-21 SCHAFFER DERACE L Director Buy 18,331 $2.08 $38,215 No
2017-08-25 SCHAFFER DERACE L Director Buy 67,326 $2.25 $151,282 No
2017-08-23 Drutz David Director Buy 10,000 $2.21 $22,097 No
2017-08-23 SCHAFFER DERACE L Director Buy 50,000 $2.21 $110,263 No
2017-06-02 GILL JOHN Director Buy 1,000 $4.34 $4,344 No
2016-12-09 PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 10%-Owner Sell 1,354,632 $3.26 $4,411,696 No
2016-04-13 RICHMAN ERIC I Director Sell 329,354 $2.20 $724,579 Yes
2016-04-08 RICHMAN ERIC I Director Sell 11,767 $2.20 $25,887 Yes
2015-03-19 St Peter Steven Director Buy 25,000 $1.65 $41,212 No
2015-01-07 CHANG LINDA L SVP, CFO & Secretary Sell 29,600 $2.10 $62,160 Yes

Insider Smart

Axsome Therapeutics, Inc (AXSM) - AXSM shows the power of an #allgreen stock, no insider selling, great management great company, if you follow the insiders last year and pick up around $25, the 52 week high is $100+.

Insider Smart

Altimmune, Inc. (ALT) - Venrock Healthcare Capital Partners III, L.P., 10%-owner of ALT bought 1.3M shares in late May then added another 1.5M shares in June with an averaged ~$8 per share. 10 days after the accumulation, ALT price jumped to $10.